Treace Medical Concepts, Inc.
TMCI
$2.78
-$0.06-1.94%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.04% | 17.96% | 14.75% | 92.02% | 12.33% |
| Total Depreciation and Amortization | 28.79% | 21.74% | 28.92% | -2.52% | 37.92% |
| Total Amortization of Deferred Charges | 1.35% | 0.00% | -1.33% | 87.28% | -1.33% |
| Total Other Non-Cash Items | 23.66% | 12.21% | 24.85% | 69.50% | 30.40% |
| Change in Net Operating Assets | 22.20% | 137.46% | 394.80% | -1,022.16% | -868.25% |
| Cash from Operations | 23.22% | 78.05% | 158.14% | -890.79% | -24.48% |
| Capital Expenditure | 1.89% | -175.71% | 9.78% | -36.74% | 18.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.84% | -93.75% | -78.54% | -10.48% | 6.52% |
| Cash from Investing | 51.59% | -114.52% | -150.40% | -31.68% | 25.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,912.50% | -62.70% | 128.85% | -67.98% | -99.90% |
| Repurchase of Common Stock | -- | -- | -69.20% | -138.46% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -225.00% | 217.36% | -52.43% | -84.24% | -94.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.97% | -160.13% | 155.43% | -113.32% | -27.62% |